These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17298404)

  • 1. Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy.
    Kanai H; Marushima H; Kimura N; Iwaki T; Saito M; Maehashi H; Shimizu K; Muto M; Masaki T; Ohkawa K; Yokoyama K; Nakayama M; Harada T; Hano H; Hataba Y; Fukuda T; Nakamura M; Totsuka N; Ishikawa S; Unemura Y; Ishii Y; Yanaga K; Matsuura T
    Artif Organs; 2007 Feb; 31(2):148-51. PubMed ID: 17298404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases].
    Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up by one- and two-dimensional NMR of plasma from pigs with ischemia-induced acute liver failure treated with a bioartificial liver.
    Tréhout D; Desille M; Doan BT; Mahler S; Frémond B; Mallédant Y; Campion JP; Desbois J; Beloeil JC; de Certaines J; Clément B
    NMR Biomed; 2002 Oct; 15(6):393-403. PubMed ID: 12357553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
    Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
    J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioartificial liver that combines plasma dialysis and whole liver perfusion.
    Umehara M; Totsuka E; Ishizawa Y; Nara M; Hakamada K; Umehara Y; Sasaki M
    Hepatogastroenterology; 2008; 55(85):1216-21. PubMed ID: 18795660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
    Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
    Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in bioreactors of bioartificial livers.
    Yu CB; Pan XP; Li LJ
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro morphological and functional characterization of isolated porcine hepatocytes for extracorporeal liver support: bile acid uptake and conjugation.
    Morsiani E; Pazzi P; Moscioni AD; Rozga J; Azzena G; Demetriou AA
    J Surg Res; 1998 Sep; 79(1):54-60. PubMed ID: 9735240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver support effect of experimental extracorporeal bioartificial liver].
    Wang Y; Li M; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):31-3. PubMed ID: 10366983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive gene expression analysis of human hepatocellular carcinoma cell lines as components of a bioartificial liver using a radial flow bioreactor.
    Kosuge M; Takizawa H; Maehashi H; Matsuura T; Matsufuji S
    Liver Int; 2007 Feb; 27(1):101-8. PubMed ID: 17241388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A step towards a bioartificial liver: temporary extracorporeal replacement using isolated hepatocytes].
    Clément B; Frémond B; Joly A; Desjardins JF; Campion JP; Guillouzo A; Bourel M
    Bull Acad Natl Med; 1996 Oct; 180(7):1753-63; discussion 1764-7. PubMed ID: 9102156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure.
    Detry O; Arkadopoulos N; Ting P; Kahaku E; Watanabe FD; Rozga J; Demetriou AA
    Am Surg; 1999 Oct; 65(10):934-8. PubMed ID: 10515538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum S100b (astrocyte-specific protein) is a useful marker of hepatic encephalopathy in patients with fulminant hepatitis.
    Isobe-Harima Y; Terai S; Segawa M; Uchida K; Yamasaki T; Sakaida I
    Liver Int; 2008 Jan; 28(1):146-7. PubMed ID: 18173564
    [No Abstract]   [Full Text] [Related]  

  • 15. Does the extend of the culture time of primary hepatocytes in a bioreactor affect the treatment efficacy of a bioartificial liver?
    Flendrig LM; Maas MA; Daalhuisen J; Ladiges NC; La Soe JW; Te Velde AA; Chamuleau RA
    Int J Artif Organs; 1998 Sep; 21(9):542-7. PubMed ID: 9828060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy.
    Park J; Masaki T; Mezaki Y; Yokoyama H; Nakamura M; Maehashi H; Fujimi TJ; Gouraud SS; Nagatsuma K; Nakagomi M; Kimura N; Matsuura T
    PLoS One; 2017; 12(12):e0189346. PubMed ID: 29216295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
    Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson J; Koutalistras N; Wang L
    Int J Artif Organs; 1998 Jan; 21(1):43-8. PubMed ID: 9554825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary neurological improvement in a patient with acute or chronic liver failure treated with a bioartificial liver device.
    Donini A; Baccarani U; Risaliti A; Degrassi A; Bresadola F
    Am J Gastroenterol; 2000 Apr; 95(4):1102-4. PubMed ID: 10763984
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure.
    Enosawa S; Miyashita T; Fujita Y; Suzuki S; Amemiya H; Omasa T; Hiramatsu S; Suga K; Matsumura T
    Cell Transplant; 2001; 10(4-5):429-33. PubMed ID: 11549067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-animal models of fulminant hepatic failure.
    Takada Y; Ishiguro S; Fukunaga K
    J Artif Organs; 2003; 6(1):9-13. PubMed ID: 14598118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.